In each episode of "Goldman Sachs Exchanges," people from the firm share their insights on developme
Twenty-five years ago, Goldman Sachs research analyst Kathy Matsui wrote a report about the Japanese
The rapid unwinding of the Japanese yen carry trade is rippling through global markets. Goldman Sach
Global markets sold off sharply amid rising US recession fears. Goldman Sachs Research’s Chief US Ec
“Tectonic shifts” are reshaping the private markets and spurring consolidation among alternative ass
The US consumer has powered the global economy in recent years, but are signs of strain starting to
Ares Management’s Co-founder, CEO, and President Mike Arougheti shares his outlook for the economy a
Tech giants and beyond are set to spend an estimated $1 trillion on AI capex in coming years. Will t
Rising incomes and slowing electric vehicles sales are slowing the world’s transition away from oil.
Can US stocks sustain their rally from here? Goldman Sachs Research’s David Kostin, chief US equity
Long-time large-cap growth manager Kathleen McCarragher of Jennison Associates speaks with Goldman S
As two of Europe's three largest economies head to the polls, what are markets telling us about the
Goldman Sachs’ Christian Mueller-Glissmann and Alexandra Wilson-Elizondo discuss their outlooks for
The demand for power, driven in part by the rise of generative artificial intelligence, is set to gr
The Federal Reserve has historically led a relatively synchronized monetary policy cycle across the
On this episode of Goldman Sachs Exchanges, Goldman Sachs Research’s Alex Blostein joins moderator A
After better-than-expected economic data kicking off the year, and a blistering start for the equity
Is it possible to have a positive impact through investing without giving up on returns? Brian Singe
Goldman Sachs Research's Jari Stehn joins Charlotte Keenan of the firm's Office of Corporate Engagem
Recent weakness in US Treasury bond auctions have become a focal point for markets. Goldman Sachs’ J
The newest generation of GLP-1 drugs are being hailed by some as “miracle drugs” for the treatment o
